Alembic Pharma announces successful completion of USFDA inspection at Aleor Dermaceuticals

Aleor Dermaceuticals is a 60:40 Joint Venture (JV) between Alembic Pharmaceuticals and Orbicular Pharmaceutical Technologies,the company said in a BSE filing.

from India Infoline News Service https://ift.tt/2TcpkpX